drugset / Trial / NCT05966688
A Study to Evaluate the Effect of Co-administration on the Pharmacokinetics of SPR720, Azithromycin, and Ethambutol in Healthy Participants
Non-randomizedSequentialOpen-labelTreatment
Summary
The primary purpose of this study is to evaluate the pharmacokinetics (PK) of SPR720, azithromycin, and ethambutol, administered separately and co-administered, in healthy adult participants.
Timeline
- Start
- 2023-08-04
- Primary completion
- 2024-01-30
- Completion
- 2024-02-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | 500 mg | Oral |
| Subject | Ethambutol | Small molecule | 800 mg | Oral |
| Subject | SPR720 | Small molecule | 1000 mg | Oral |
Indications
No indication recorded.